GO:0006400 tRNA modification: Epitranscriptomic Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006400 (tRNA modification) describes the covalent alteration of nucleotides within a tRNA molecule, producing a sequence that differs from the genetically coded sequence.
• tRNA modifications are essential for tRNA folding, stability, codon recognition, and translational fidelity, and their dynamic regulation is now recognized as a layer of epitranscriptomic control.
• Dysregulation of tRNA modification enzymes is linked to cancer, neurological disorders, and mitochondrial diseases, making these enzymes attractive therapeutic targets.
• Key modification enzymes include TRMT6/TRMT61A (m1A), ADAT2/ADAT3 (A-to-I), and queuosine pathway enzymes, each with distinct roles in translation and disease.
• Advanced methods such as mim-tRNAseq enable high-resolution quantitative profiling of tRNA abundance and modification status, accelerating functional studies.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models are powerful tools to dissect the causal roles of tRNA modification genes in physiology and disease.
Description
tRNA modification (GO:0006400) is a fundamental biological process in which nucleotides within a transfer RNA molecule are covalently altered after transcription, generating a tRNA whose sequence differs from that encoded in the genome. These chemical modifications are not mere decorations; they are critical for tRNA folding, stability, and function in protein synthesis. Over 170 distinct RNA modifications have been described, and tRNAs carry the highest density of modifications among all RNA species. The dynamic nature of these modifications has led to the concept of the tRNA epitranscriptome, which integrates environmental and metabolic signals to fine-tune translation. Recent advances in sequencing technologies, such as mim-tRNAseq, have enabled quantitative profiling of tRNA abundance and modification status at high resolution, revealing that tRNA modification levels vary across tissues, developmental stages, and disease states. This has spurred interest in understanding how individual modification enzymes contribute to cellular physiology and how their dysregulation leads to disease. For example, TRMT6-mediated m1A modification acts as a translational checkpoint for histone synthesis and promotes colorectal cancer progression, while ADAT2-mediated A-to-I modification enhances oncogenic translation and chemoresistance in colorectal cancer. Given the growing recognition of tRNA modifications as key regulators of gene expression, researchers require robust models and methods to study these processes. This article provides a comprehensive overview of GO:0006400, covering its definition, mechanisms, key genes, disease relevance, and state-of-the-art research tools, with a focus on CRISPR-based approaches for functional dissection.
tRNA modification At A Glance
| GO ID | GO:0006400 |
|---|---|
| GO term | tRNA modification |
| Ontology | biological_process |
| Synonym | tRNA editing |
| Definition | The covalent alteration of one or more nucleotides within a tRNA molecule to produce a tRNA molecule with a sequence that differs from that coded genetically. |
| Major function | Ensures tRNA folding, stability, codon-anticodon pairing, and translational fidelity; contributes to epitranscriptomic regulation. |
| Related processes | tRNA processing, RNA methylation, RNA editing, translation regulation. |
| Disease relevance | Cancer, neurological disorders, mitochondrial diseases, and chemoresistance. |
What Is GO:0006400?
According to the Gene Ontology, GO:0006400 (tRNA modification) is defined as the covalent alteration of one or more nucleotides within a tRNA molecule to produce a tRNA molecule with a sequence that differs from that coded genetically. This process encompasses a wide range of chemical modifications, including methylation, deamination, thiolation, and isomerization, which are introduced post-transcriptionally by dedicated enzymes. The synonym tRNA editing is sometimes used, although editing typically refers to a subset of modifications that change the coding properties of tRNA. These modifications are essential for the proper structure and function of tRNA in translation.
Why Is tRNA modification Important in Cell Biology?
tRNA modifications are indispensable for accurate and efficient protein synthesis, and their dynamic regulation constitutes a critical layer of post-transcriptional gene expression control. Disruption of tRNA modification enzymes leads to translational defects, protein aggregation, and cellular stress, which are associated with a growing list of human diseases, including cancer, neurodegeneration, and mitochondrial disorders. Moreover, the interplay between tRNA modifications and tRNA processing pathways influences tRNA maturation and quality control. Understanding GO:0006400 is therefore essential for deciphering the molecular basis of translation regulation and for developing therapeutic strategies targeting the tRNA epitranscriptome.
• tRNA modifications ensure translational fidelity by stabilizing codon-anticodon interactions and preventing frameshifting.
• They regulate tRNA stability and processing, with defects leading to tRNA degradation and cellular stress.
• Dynamic changes in tRNA modifications allow cells to adapt translation to environmental cues and metabolic states.
• Dysregulation of modification enzymes such as TRMT6 and ADAT2 drives cancer progression and chemoresistance.
• Queuosine modification connects the microbiome to host translation, influencing health and disease.
• tRNA modification defects are implicated in neurological disorders and mitochondrial diseases.
• Plant pathogenic fungi rely on tRNA modifications for pathogenicity, highlighting agricultural relevance.
• High-resolution profiling methods like mim-tRNAseq enable quantitative analysis of modification dynamics.
• CRISPR-based models facilitate functional studies of modification enzymes in disease contexts.
• Targeting tRNA modification pathways offers new avenues for therapeutic intervention.
What Happens During tRNA modification?
Recognition and Recruitment of Modification Enzymes
In simple terms: Enzymes find specific spots on tRNA and get ready to modify them.
The process begins with the recognition of tRNA substrates by modification enzymes, which often involves specific sequence or structural elements within the tRNA molecule. These enzymes are recruited to the nascent tRNA during or after transcription, and their activity can be regulated by cellular signals. For example, the m1A methyltransferase complex TRMT6/TRMT61A recognizes specific tRNA structures to install m1A at position 58, a modification that influences tRNA stability and translation. Similarly, ADAT2/ADAT3 catalyzes adenosine-to-inosine (A-to-I) editing at the wobble position of tRNA, which expands codon recognition and promotes oncogenic translation.
Catalytic Modification Reactions
In simple terms: The enzymes chemically change the tRNA letters, like adding small tags.
Once bound, modification enzymes catalyze covalent changes to nucleotide bases or ribose sugars. These reactions include methylation (e.g., m1A, m2,2G), deamination (A-to-I), thiolation (s2U), and isomerization (queuosine). Each modification is introduced by a dedicated enzyme or complex, and the chemical diversity of modifications allows tRNAs to fine-tune their interactions with ribosomes and translation factors. The catalytic mechanisms often require cofactors such as S-adenosylmethionine (SAM) for methylation or iron-sulfur clusters for thiolation. The interplay between different modifications and tRNA processing events ensures proper tRNA maturation.
Modification Dynamics and Epitranscriptomic Regulation
In simple terms: The tags on tRNA can be added or removed, like switches that control translation.
tRNA modifications are not static; they can be dynamically regulated in response to cellular conditions, giving rise to the concept of the tRNA epitranscriptome. For instance, queuosine modification levels vary with microbiome status and influence the translatome. Dynamic changes in m1A and A-to-I modifications have been observed during cancer progression and stress responses. This dynamic regulation allows cells to rapidly adjust translation efficiency and fidelity, and it involves crosstalk with tRNA processing and quality control pathways.
Functional Consequences for Translation
In simple terms: The modified tRNA works better in making proteins, affecting how genes are expressed.
Modified tRNAs exhibit enhanced stability, improved codon-anticodon pairing, and altered interactions with the ribosome, leading to more efficient and accurate translation. Specific modifications at the wobble position (e.g., queuosine, inosine) expand decoding capacity and influence the speed of translation. In cancer, TRMT6-mediated m1A modification acts as a translational checkpoint for histone synthesis, supporting cell proliferation. Thus, tRNA modifications directly impact the proteome and cellular phenotypes.
Quality Control and Turnaround
In simple terms: Cells check the tRNA tags and remove faulty tRNAs.
Cells monitor tRNA integrity through quality control pathways that detect improperly modified or misfolded tRNAs and target them for degradation. The interplay between modification and processing ensures that only correctly modified tRNAs enter the translation pool. Defects in modification can trigger tRNA decay and stress responses, linking GO:0006400 to cellular homeostasis.
Key Genes Involved in GO:0006400 tRNA modification
The following genes encode enzymes and factors that catalyze or regulate tRNA modifications, and they are frequently studied in the context of GO:0006400.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TRMT6 | Component of the m1A methyltransferase complex; installs m1A at tRNA position 58 | Linked to colorectal cancer progression and histone synthesis checkpoint |
| TRMT61A | Catalytic subunit of the m1A methyltransferase complex | Partner of TRMT6; involved in tRNA modification and cancer |
| ADAT2 | Catalytic subunit of the A-to-I tRNA editing enzyme | Promotes oncogenic translation and chemoresistance in colorectal cancer |
| ADAT3 | Regulatory subunit of the A-to-I tRNA editing enzyme | Mutations cause intellectual disability; involved in tRNA editing |
| TRMT1 | Dimethylates guanosine at position 26 (m2,2G) in tRNA | Associated with intellectual disability and neurological disorders |
| FTSJ1 | 2'-O-methylates tRNA at position 32 and 34 | X-linked intellectual disability; involved in tRNA modification |
| PUS1 | Pseudouridylates tRNA at multiple positions | Mitochondrial myopathy and sideroblastic anemia; tRNA modification |
| PUS3 | Pseudouridylates tRNA at position 39 | Intellectual disability; tRNA modification |
| DKC1 | Pseudouridylates rRNA and tRNA; component of telomerase | Dyskeratosis congenita; tRNA modification |
| NSUN2 | Methylates cytosine at position 34 (m5C) in tRNA | Intellectual disability and cancer; tRNA modification |
| ALKBH8 | Hydroxylates wybutosine and methylates tRNA | Cancer and oxidative stress response; tRNA modification |
| TRIT1 | Isopentenylates adenosine at position 37 (i6A) in tRNA | Mitochondrial disease and cancer; tRNA modification |
| CDKAL1 | Methylthiotransferase that modifies tRNA-Lys (ms2t6A) | Type 2 diabetes and insulin secretion; tRNA modification |
| GTPBP3 | Modifies tRNA at position 34 (nm5s2U) in mitochondria | Mitochondrial diseases; tRNA modification |
| MTO1 | Modifies tRNA at position 34 in mitochondria | Mitochondrial cardiomyopathy; tRNA modification |
| TRMU | Thiolates tRNA at position 34 in mitochondria | Mitochondrial disease and deafness; tRNA modification |
| QTRT1 | Catalyzes queuosine modification of tRNA | Microbiome-host interactions; tRNA modification |
| QTRT2 | Partner of QTRT1 in queuosine modification | Queuosine tRNA modification and translation |
How Is tRNA modification Regulated?
tRNA modification is regulated at multiple levels. The expression of modification enzymes can be controlled transcriptionally and post-translationally in response to cellular signals, including nutrient availability and stress. For example, mTOR signaling influences tRNA modification dynamics to coordinate translation with growth. The integrated stress response (ISR) can also modulate tRNA modification patterns, although specific mechanisms are still being elucidated. Additionally, the availability of cofactors such as SAM links tRNA methylation to metabolic status. Crosstalk between modifications and tRNA processing ensures that only properly modified tRNAs are functional.
tRNA modification and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TRMT6 | Colorectal cancer progression | Knockout and overexpression in HCT116 and SW480 cell lines |
| ADAT2 | Colorectal cancer and chemoresistance | Knockout and point mutation in patient-derived organoids |
| TRMT1 | Intellectual disability | Knockout and knock-in in iPSC-derived neurons |
| FTSJ1 | X-linked intellectual disability | Knockout and overexpression in SH-SY5Y cells |
| PUS1 | Mitochondrial myopathy and sideroblastic anemia | Knockout and point mutation in HEK293T and patient fibroblasts |
tRNA Modifications in Cancer
Dysregulation of tRNA modification enzymes is increasingly recognized as a driver of cancer. TRMT6-mediated m1A modification acts as a translational checkpoint for histone synthesis, facilitating colorectal cancer progression. ADAT2-mediated A-to-I editing promotes oncogenic translation and chemoresistance in colorectal cancer. These findings highlight tRNA modifications as potential therapeutic targets and biomarkers in oncology.
Neurological Disorders and Intellectual Disability
Mutations in tRNA modification genes such as TRMT1, FTSJ1, PUS3, and NSUN2 are associated with intellectual disability and neurological phenotypes. These defects impair tRNA function and translation in neurons, underscoring the importance of tRNA modifications for brain development and function.
Mitochondrial Diseases
Mitochondrial tRNA modifications are critical for oxidative phosphorylation. Mutations in GTPBP3, MTO1, TRMU, and PUS1 cause mitochondrial diseases including cardiomyopathy, encephalopathy, and sideroblastic anemia. These disorders highlight the tissue-specific vulnerability to tRNA modification defects.
Microbiome and Metabolic Disorders
Queuosine tRNA modification connects the microbiome to the host translatome, influencing translation and potentially metabolic health. CDKAL1-mediated tRNA modification is linked to type 2 diabetes risk, illustrating the intersection of tRNA modifications with metabolic diseases.
From tRNA modification-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TRMT6 affect tRNA m1A levels and translation? | TRMT6 knockout cell lines (e.g., HCT116) with mim-tRNAseq and polysome profiling |
| Does ADAT2 A-to-I editing promote chemoresistance? | ADAT2 knockout and point-mutation (catalytic dead) in colorectal cancer cells |
| What is the role of queuosine modification in translation? | QTRT1 knockout and knock-in of modified tRNA in cell lines |
| How do mitochondrial tRNA modifications affect OXPHOS? | GTPBP3 or MTO1 knockout in HEK293T and mitochondrial respiration assays |
| Can overexpression of TRMT6 drive tumorigenesis? | TRMT6 overexpression in mouse xenograft models |
| What are the dynamic changes in tRNA modifications under stress? | Inducible knockout or overexpression of modification enzymes combined with mim-tRNAseq |
How to Study the tRNA modification Process
| Method | What It Measures | Typical Application |
|---|---|---|
| mim-tRNAseq | tRNA abundance and modification status at high resolution | Profiling dynamic tRNA modifications in cells and tissues |
| Ribo-seq | Ribosome occupancy and translation efficiency | Assessing translational impact of tRNA modification loss |
| Polysome profiling | Distribution of mRNAs across polysomes | Validating translation defects in knockout models |
| LC-MS/MS | Quantification of modified nucleosides | Global analysis of tRNA modification changes |
| CRISPR knockout screens | Gene essentiality and drug sensitivity | Identifying tRNA modification genes required for cancer growth |
| CRISPR activation (CRISPRa) | Gene overexpression | Studying gain-of-function of modification enzymes |
| Bioinformatics pipelines | Integration of multi-omics data | Metaepitranscriptomics of microbiomes and disease |
| In vitro modification assays | Enzymatic activity of modification enzymes | Validating catalytic activity of mutants |
High-Resolution tRNA Modification Profiling
mim-tRNAseq enables quantitative profiling of tRNA abundance and modification status at single-nucleotide resolution, allowing researchers to map dynamic changes in tRNA modifications across conditions. This method is essential for studying the epitranscriptome and validating the effects of CRISPR perturbations.
Translational Profiling (Ribo-seq and Polysome Profiling)
Ribosome profiling (Ribo-seq) and polysome profiling measure translation efficiency and ribosome occupancy, revealing how tRNA modifications impact protein synthesis. These techniques can be combined with CRISPR knockout of modification enzymes to assess translational consequences.
Mass Spectrometry and RNA Modification Detection
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) allows direct quantification of modified nucleosides in tRNA, providing a global view of modification changes. This method complements sequencing-based approaches and is useful for validating specific modifications.
CRISPR Screening and Functional Genomics
Pooled CRISPR screens targeting tRNA modification enzymes can identify genes essential for cell growth, stress resistance, or drug sensitivity. Such screens, coupled with bioinformatics analysis, uncover pathways and networks regulated by tRNA modifications.
How CRISPR Can Be Used to Study GO:0006400 tRNA modification
Knockout
CRISPR knockout of tRNA modification genes (e.g., TRMT6, ADAT2) enables loss-of-function studies to determine their roles in tRNA modification, translation, and disease phenotypes. Knockout cell lines can be subjected to mim-tRNAseq and polysome profiling to link specific modifications to translational outputs.
Point Mutation
Introducing catalytic-dead point mutations (e.g., in ADAT2) via CRISPR base editing or homology-directed repair allows separation of enzymatic activity from scaffolding functions. Such models are crucial for understanding the precise contribution of modification activity to oncogenic translation.
Knock-in
Knock-in of tagged or mutant versions of modification enzymes (e.g., FLAG-tagged TRMT6) facilitates biochemical purification and interaction studies. Knock-in of disease-associated mutations (e.g., in TRMT1) can model neurological disorders in iPSC-derived neurons.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression of modification enzymes (e.g., TRMT6, ADAT2) can drive tumorigenesis and reveal gain-of-function phenotypes. Overexpression models are useful for studying the sufficiency of a modification in promoting translation and cancer progression.
How EDITGENE Supports tRNA modification Research
Researchers studying tRNA modification-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. This requires precise genetic models that can knockout, mutate, knock-in, or overexpress the gene of interest, coupled with functional readouts such as tRNA modification profiling and translation assays. EDITGENE provides end-to-end CRISPR solutions to accelerate such studies.
Contact EDITGENE today to design your custom CRISPR model for tRNA modification research.
Frequently Asked Questions About tRNA modification
What is GO:0006400?
GO:0006400 is the Gene Ontology term for tRNA modification, defined as the covalent alteration of one or more nucleotides within a tRNA molecule to produce a tRNA molecule with a sequence that differs from that coded genetically.
What genes are involved in tRNA modification?
Key genes include TRMT6, TRMT61A, ADAT2, ADAT3, TRMT1, FTSJ1, PUS1, PUS3, DKC1, NSUN2, ALKBH8, TRIT1, CDKAL1, GTPBP3, MTO1, TRMU, QTRT1, and QTRT2, among others.
How does tRNA modification affect translation?
tRNA modifications enhance tRNA stability, codon-anticodon pairing, and ribosome interactions, thereby improving translation efficiency and fidelity. Dynamic modifications can act as translational checkpoints.
What diseases are linked to tRNA modification defects?
Defects are linked to cancer, intellectual disability, mitochondrial diseases, and metabolic disorders such as type 2 diabetes.
What methods are used to study tRNA modifications?
Methods include mim-tRNAseq, Ribo-seq, polysome profiling, LC-MS/MS, and CRISPR screens.
How can CRISPR help study tRNA modification?
CRISPR enables knockout, point mutation, knock-in, and overexpression of modification enzymes to dissect their causal roles in translation and disease.
What is the role of TRMT6 in cancer?
TRMT6-mediated m1A modification acts as a translational checkpoint for histone synthesis and facilitates colorectal cancer progression.
What is queuosine tRNA modification?
Queuosine modification connects the microbiome to the host translatome, influencing translation and health.
Are tRNA modifications dynamic?
Yes, tRNA modifications are dynamically regulated in response to cellular conditions, forming the tRNA epitranscriptome.
How does EDITGENE support tRNA modification research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression models, library screening, and bioinformatics services for tRNA modification studies.
Conclusion
GO:0006400 (tRNA modification) is a vital biological process that ensures proper tRNA function and translational control. Its dynamic regulation and widespread impact on cellular physiology make it a focal point for understanding gene expression and disease. With advanced tools like mim-tRNAseq and CRISPR-based models, researchers can now dissect the precise roles of individual modifications and their enzymes. EDITGENE offers comprehensive services to accelerate these discoveries, from custom cell models to high-throughput screening and bioinformatics.
References
- 1. Behrens A et al.. 2021. High-resolution quantitative profiling of tRNA abundance and modification status in eukaryotes by mim-tRNAseq.. Mol Cell 81(8):1802-1815.e7 PMID: 33581077
- 2. Zhang W et al.. 2022. tRNA modification dynamics from individual organisms to metaepitranscriptomics of microbiomes.. Mol Cell 82(5):891-906 PMID: 35032425
- 3. Peschek J et al.. 2025. Interplay Between tRNA Modifications and Processing.. J Mol Biol 437(16):169198 PMID: 40404521
- 4. Tao EW et al.. 2025. TRMT6-mediated tRNA m(1)A modification acts as a translational checkpoint of histone synthesis and facilitates colorectal cancer progression.. Nat Cancer 6(8):1458-1476 PMID: 40461825
- 5. Lv Z et al.. 2025. tRNA modification in plant pathogenic fungi: roles, mechanisms, and implications for pathogenicity.. New Phytol 247(2):527-532 PMID: 40452131
- 6. Rashad S. 2025. Queuosine tRNA Modification: Connecting the Microbiome to the Translatome.. Bioessays 47(2):e202400213 PMID: 39600051
- 7. Cheng CH et al.. 2026. ADAT2-mediated A-to-I tRNA modification promotes oncogenic translation and colorectal cancer progression and chemoresistance.. Mol Cancer 25(1) PMID: 41845367
- 8. Suzuki T. 2021. The expanding world of tRNA modifications and their disease relevance.. Nat Rev Mol Cell Biol 22(6):375-392 PMID: 33658722
